News on a breakthrough drug from Keryx (Nasdaq: KERX) was bungled by the misinformed media - so get in on this stock at a deep discount. News on a breakthrough drug from Keryx (Nasdaq: KERX) was bungled by the misinformed media ...
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval ... But the question is, even with successful clinical trials and FDA approval, why did the Keryx stock price fall so much after the approval?
Investors in Keryx Biopharmaceuticals, Inc. KERX need to pay close attention to the stock based on moves in the options market lately. That is because the January 19, 2018 $3 Put had some of the highest implied volatility of all equity …
Keryx Biopharmaceuticals (NASDAQ:KERX - News) stock gained 5.94% to $2.14 +0.12 after the company announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 7th Annual JMP Securities Healthcare …
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today the initiation of its short-term Phase 3 study of Zerenex (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or …
ticker=KERX Alder BioPharmaceuticals, Inc. https://rdinvesting.com/news/?ticker=ALDR Keryx Biopharmaceuticals …